{
  "trial_id": "NCT00783393",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "histologically confirmed anaplastic astrocytoma on the tentorium at first relapse",
      "label": "met",
      "evidence": "anaplastic astrocytoma of the spine complicated by severe lower extremity weakness and urinary retention s/p Foley catheter"
    },
    {
      "criterion": "unequivocal evidence of tumor recurrence or aggravation by MRI scan after treatment for initial onset",
      "label": "met",
      "evidence": "MRI showed a spinal cord conus mass which was biopsied and found to be anaplastic astrocytoma"
    },
    {
      "criterion": "anaplastic astrocytoma diagnosed histologically by the last pathological diagnostic tests (including initial diagnosis) prior to initial administration of temozolomide",
      "label": "met",
      "evidence": "MRI showed a spinal cord conus mass which was biopsied and found to be anaplastic astrocytoma"
    },
    {
      "criterion": "tissue samples available for Central Pathologic Reviewer",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "pathologic diagnosis report by the study-conducting medical institution must be available for the sponsor",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "MRI scan performed within 14 days before initial temozolomide administration",
      "label": "met",
      "evidence": "MRI scan performed within 14 days before initial temozolomide administration; assessable tumor site confirmed by MRI"
    },
    {
      "criterion": "age >=18 years, either sex, inpatients or outpatients",
      "label": "met",
      "evidence": "Patient is a 45-year-old man"
    },
    {
      "criterion": "Karnofsky performance status >=70",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "History of treatment with dacarbazine",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "Subjects who received chemotherapy within 6 weeks before initial temozolomide administration",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subjects who completed radiotherapy within 12 weeks before initial temozolomide administration",
      "label": "does_not_trigger",
      "evidence": "none"
    }
  ],
  "notes": "Unknown: tissue samples available for Central Pathologic Reviewer, pathologic diagnosis report by the study-conducting medical institution must be available for the sponsor, Karnofsky performance status >=70",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00783393",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b"
  }
}